2026 in pharma — approvals, patent cliffs, Phase 3 readouts

Every FDA approval, patent expiry, and pivotal Phase 3 readout tracked for 2026: 0 approvals, 177 patent expiries, 0 Phase 3 milestones.

20242025202620272028

FDA / EMA / MHRA approvals (0)

No entries tracked.

Patent expiries (177)

Phase 3 readouts (0)

No entries tracked.